{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:41:55Z","timestamp":1791747715275,"version":"4.3.4"},"reference-count":41,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Human parvovirus B19 (B19V) has a wide clinical spectrum, ranging from an asymptomatic infection to a life threatening one. During pregnancy, it can lead to fetal loss and hydrops fetalis. This retrospective study examined the incidence rates of B19V in Israel, analyzing anonymized electronic medical records of 2.7 million individuals between January 2015 and September 2023. A generalized linear model with a Poisson distribution was fit to the data, adjusting for potential confounders. A marked increase in B19V was observed in 2023, with an adjusted incidence rate ratio (IRR) of 6.6 (95% CI 6.33\u20136.89) when comparing 2023 to previous years. When specifically comparing 2023 to COVID-19 years (2020\u20132022), adjusted IRR climbs to 9.21 (8.66\u20139.80). Moreover, in 2023, previously existing seasonality has largely disappeared. High SES characterized most infected individuals with a marked discrepancy in social sectors; the Arab population was significantly less likely to be found B19V positive, even when adjusting for SES. Most infections occurred in school-aged children (6\u201311 years old). Pregnant women experienced the most significant rise in B19V, with an adjusted IRR of 11.47 (9.44\u201313.97) in 2023 compared to previous years; most cases were diagnosed in the first trimester. This study demonstrates that Israel is currently experiencing the largest and longest reported outbreak of B19V to date. Policymakers should consider setting screening policies in place, at least for populations at risk, while specifically studying and potentially targeting low socioeconomic populations and specific social sectors to avoid health inequalities.<\/jats:p>","DOI":"10.3390\/v15112261","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T07:11:27Z","timestamp":1700118687000},"page":"2261","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["An Outbreak of Parvovirus B19 in Israel"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7415-1053","authenticated-orcid":false,"given":"Tal","family":"Patalon","sequence":"first","affiliation":[{"name":"Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv 68125, Israel"},{"name":"Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv 68125, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaki","family":"Saciuk","sequence":"additional","affiliation":[{"name":"Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv 68125, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Trotzky","sequence":"additional","affiliation":[{"name":"Shamir Medical Center (Assaf Harofeh Medical Center), Zerifin 70300, Israel"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gal","family":"Pachys","sequence":"additional","affiliation":[{"name":"Shamir Medical Center (Assaf Harofeh Medical Center), Zerifin 70300, Israel"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ben-Tov","sequence":"additional","affiliation":[{"name":"Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv 68125, Israel"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaakov","family":"Segal","sequence":"additional","affiliation":[{"name":"Maccabi Healthcare Services, Tel Aviv 68125, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9875-3550","authenticated-orcid":false,"given":"Sivan","family":"Gazit","sequence":"additional","affiliation":[{"name":"Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv 68125, Israel"},{"name":"Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv 68125, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Auriti, C., De Rose, D.U., Santisi, A., Martini, L., Piersigilli, F., Bersani, I., Ronchetti, M.P., and Caforio, L. (2021). Pregnancy and viral infections: Mechanisms of fetal damage, diagnosis and prevention of neonatal adverse outcomes from cytomegalovirus to SARS-CoV-2 and Zika virus. Biochim. Biophys. Acta Mol. Basis. Dis, 1867.","DOI":"10.1016\/j.bbadis.2021.166198"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"100007","DOI":"10.1016\/j.amolm.2023.100007","article-title":"Parvovirus B19: Insights and implication for pathogenesis, prevention and therapy","volume":"1","author":"Zakrzewska","year":"2023","journal-title":"Asp. Mol. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/pd.5819","article-title":"Identification and management of congenital parvovirus B19 infection","volume":"40","author":"Attwood","year":"2020","journal-title":"Prenat. Diagn."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coviro.2017.10.003","article-title":"Parvovirus B19 infection in pregnancy\u2014Awareness and opportunities","volume":"27","author":"Bonvicini","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00006454-198708000-00003","article-title":"Role of parvovirus B19 in human disease","volume":"6","author":"Anderson","year":"1987","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMra030840","article-title":"Parvovirus B19","volume":"350","author":"Young","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/infdis\/154.3.383","article-title":"The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease)","volume":"154","author":"Chorba","year":"1986","journal-title":"J. Infect. Dis."},{"key":"ref_8","first-page":"573","article-title":"Fifth disease: Report of an outbreak","volume":"34","author":"Andrews","year":"1984","journal-title":"J. R. Coll. Gen. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaad.2014.02.044","article-title":"Different patterns of skin manifestations associated with parvovirus B19 primary infection in adults","volume":"71","author":"Mage","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0140-6736(11)60554-0","article-title":"Papular-purpuric gloves and socks syndrome","volume":"378","author":"Gutermuth","year":"2011","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.revmed.2004.02.026","article-title":"Systemic manifestations of Parvovirus B19 infections","volume":"25","author":"Ferry","year":"2004","journal-title":"Rev. Med. Interne"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/s10165-010-0338-y","article-title":"Clinical findings in parvovirus B19 infection in 30 adult patients in Kyoto","volume":"21","author":"Oiwa","year":"2011","journal-title":"Mod. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00002281-200007000-00010","article-title":"Parvovirus-associated arthritis","volume":"12","author":"Moore","year":"2000","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0140-6736(93)91145-C","article-title":"Human parvovirus infection in homozygous sickle cell disease","volume":"341","author":"Serjeant","year":"1993","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood.V67.5.1411.1411","article-title":"Human Parvovirus B19-Induced Epidemic Acute Red Cell Aplasia in Patients With Hereditary Hemolytic Anemia","volume":"67","author":"Saarinen","year":"1986","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(01)06807-6","article-title":"Haematological response to parvovirus B19 infection in homozygous sickle-cell disease","volume":"358","author":"Serjeant","year":"2001","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1128\/JCM.37.8.2483-2487.1999","article-title":"Novel human erythrovirus associated with transient aplastic anemia","volume":"37","author":"Nguyen","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1086\/599042","article-title":"Neurologic manifestations associated with parvovirus B19 infection","volume":"48","author":"Douvoyiannis","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/rmv.1782","article-title":"Neurological aspects of human parvovirus B19 infection: A systematic review","volume":"24","author":"Barah","year":"2014","journal-title":"Rev. Med. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/jcp.41.4.381","article-title":"Parvovirus as a cause of hydrops fetalis: Detection by in situ DNA hybridisation","volume":"41","author":"Porter","year":"1988","journal-title":"J. Clin. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/0002-9378(90)90681-V","article-title":"Management and outcomes of pregnancies complicated by human B19 parvovirus infection: A prospective study","volume":"163","author":"Rodis","year":"1990","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1471-0528.1998.tb10048.x","article-title":"Immediate and long term outcome of human parvovirus B19 infection in pregnancy","volume":"105","author":"Miller","year":"1998","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/pd.940","article-title":"Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: Prospective evaluation of 1018 cases","volume":"24","author":"Enders","year":"2004","journal-title":"Prenat. Diagn"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1471-0528.2000.tb13265.x","article-title":"Parvovirus B19 infection: Association with third-trimester intrauterine fetal death","volume":"107","author":"Tolfvenstam","year":"2000","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Salbetti, M.B., Pedranti, M.S., Barbero, P., Molisani, P., Lazzari, M., Olivera, N., Isa, M.B., Bertoldi, A., Moreno, L., and Adamo, M.P. (2019). Molecular screening of the human parvoviruses B19 and bocavirus 1 in the study of congenital diseases as applied to symptomatic pregnant women and children. Access Microbiol., 1.","DOI":"10.1099\/acmi.0.000037"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4103\/ijmr.IJMR_1816_16","article-title":"Genotypes of erythrovirus B19, their geographical distribution & circulation in cases with various clinical manifestations","volume":"147","author":"Jain","year":"2018","journal-title":"Indian J. Med. Res"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/S0950268815000230","article-title":"Parvovirus B19V infection in Israel: Prevalence and occurrence of acute infection between 2008 and 2013","volume":"144","author":"Mor","year":"2016","journal-title":"Epidemiol. Infect."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejogrb.2021.07.046","article-title":"Parvovirus b19 infection in pregnancy\u2014A review","volume":"264","author":"Gigi","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_29","unstructured":"Israel Central Bureau of Statistics (2019). Characterization and Classification of Geographical Units by the Socio-Economic Level of the Population 2015."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ben-Tov, A., Lebwohl, B., Banon, T., Chodick, G., Kariv, R., Assa, A., Gazit, S., and Patalon, T. (2023). BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign. Viruses, 15.","DOI":"10.3390\/v15091968"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/jmwh.13254","article-title":"Parvovirus B19 in Pregnancy: A Case Review","volume":"66","author":"Hunter","year":"2021","journal-title":"J. Midwifery Women\u2019s Health"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"McCullagh, P., and Nelder, J.A. (1989). Generalized Linear Models, Chapman & Hall\/CRC. [2nd ed.].","DOI":"10.1007\/978-1-4899-3242-6"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative Controls: A tool for detecting confounding and bias in observational studies","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00277-013-1715-3","article-title":"Thrombosis following acute cytomegalovirus infection: A community prospective study","volume":"92","author":"Paran","year":"2013","journal-title":"Ann Hematol"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(22)01277-6","article-title":"Preparing for uncertainty: Endemic paediatric viral illnesses after COVID-19 pandemic disruption","volume":"400","author":"Messacar","year":"2022","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e00253-21","DOI":"10.1128\/Spectrum.00253-21","article-title":"Lower Incidence of Parvovirus-B19 Infections in Dutch Blood Donors during SARS-CoV-2 Pandemic","volume":"9","author":"Hogema","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/vox.13229","article-title":"Changes in Parvovirus B19 positivity rates in plasma units for fractionation: An unexpected effect of non-pharmaceutical interventions against COVID-19?","volume":"117","author":"Sauleda","year":"2022","journal-title":"Vox Sang."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/tme.12893","article-title":"Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England","volume":"32","author":"Williams","year":"2022","journal-title":"Transfus. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"105576","DOI":"10.1016\/j.jcv.2023.105576","article-title":"Post-COVID-19 pandemic outbreak of severe Parvovirus B19 primary infections in Paris, France: 10-year interrupted time-series analysis (2012\u20132023)","volume":"167","author":"Fourgeaud","year":"2023","journal-title":"J. Clin. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"19249","DOI":"10.2807\/ese.14.25.19249-en","article-title":"Clinical and epidemiological aspects of parvovirus B19 infections in Ireland, January 1996\u2013June 2008","volume":"14","author":"Nicolay","year":"2009","journal-title":"Eurosurveillance"},{"key":"ref_41","first-page":"63","article-title":"Parvovirus B19 during pregnancy: A review","volume":"4","author":"Giorgio","year":"2010","journal-title":"J. Prenat. Med."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/11\/2261\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:23:58Z","timestamp":1760131438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/11\/2261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["v15112261"],"URL":"https:\/\/doi.org\/10.3390\/v15112261","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,16]]}}}